Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure
Heart Failure
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring chronic heart failure, rosuvastatin, endothelial function, skeletal muscle
Eligibility Criteria
Inclusion Criteria: chronic heart failure (NYHA class III or IV) peak oxygen uptake <20 mL/min/kg body weight left ventricular ejection fraction <30 % left ventricular end-diastolic diameter >55 mm stable medication within the last 4 weeks Exclusion Criteria: elevated GOT and GPT levels as a sign of hepatic dysfunction elevated creatinine levels as a sign of renal dysfunction insulin-dependent diabetes mellitus arterial hypertension muscle disease or elevated CK levels treatment with fibrates co-treatment with drugs that are metabolized by Cyp3A4 diseases that disallow a participation in the study
Sites / Locations
- University of Leipzig, Heart Center, Department of Internal Medicine / Cardiology